mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.4 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |